Cite
HARVARD Citation
Bose, P. et al. (2021). Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study. Clinical infectious diseases. pp. 1755-1763. [Online].